Browse by category

Levita Magnetics announced the international launch of its MARS surgical system at Hospital Luis Tisne in Santiago, Chile. This marks...

Eli Lilly and Company has announced that Zepbound (tirzepatide) injection is now available in US pharmacies for adults with obesity (with...

Roche is poised to enter the lucrative anti-obesity medication market after entering into a definitive merger agreement to acquire Carmot...

Novo Nordisk is planning a study that will see CagriSema, a new investigational medicine developed by Novo that combines Cagrilintide and...

Fractyl Health has expanded an academic-industry scientific partnership charged with advancing research on the role of the gut and...

AstraZeneca has signed an exclusive license agreement with Shanghai-based biotech Eccogene for ECC5004, an early-stage investigational...

Eli Lilly and Company has granted marketing authorisation (MA) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for...

The FDA has approved Eli Lilly and Company's Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that...

The first patient has been enrolled in Endo Tools Therapeutics’ (ETT) ESTIME clinical trial. The trial is evaluating ETT’s endomina...

Biolexis Therapeutics, a clinical-stage AI-enabled drug discovery company, has launched Metabolexis, a new pipeline company developing...